Aspirin for Preventing Cardiovascular Damage

References 

1. Wolff T , Miller T , Ko S . Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force . Ann Intern Med . 2009;150:405–410
2. U.S. Preventive Services Task Force  . Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force Recommendation Statement . Ann Intern Med . 2009;150:396–404
3. Edmunds MW , Mayhew MS . Pharmacology for the primary care provider . 3rd ed.. St Louis: Mosby; 2009;
4. Cuisset T , Frere C , Quilici J , Gaborit B , Bali L , Poyet R , et al.   Aspirin noncompliance is the major cause of “aspirin resistance” in patients undergoing coronary stenting . Am Heart J . 2009;157:889–893
   • Abstract
   • Full Text
   • Full-Text PDF (342 KB)
   • CrossRef